Related references
Note: Only part of the references are listed.Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
RITUXIMAB TREATMENT OF MYASTHENIA GRAVIS: A SYSTEMATIC REVIEW
Rup Tandan et al.
MUSCLE & NERVE (2017)
Maintenance immunosuppression in myasthenia gravis
Lauren Gotterer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
Jeffrey T. Guptill et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
A systematic review of population based epidemiological studies in Myasthenia Gravis
Aisling S. Carr et al.
BMC NEUROLOGY (2010)
Invited article: Inhibition of B cell functions - Implications for neurology
Marinos C. Dalakas
NEUROLOGY (2008)
Share Paper
